Kenichi Tanaka to Factor VIIa
This is a "connection" page, showing publications Kenichi Tanaka has written about Factor VIIa.
Connection Strength
3.975
-
Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy. Anesth Analg. 2019 08; 129(2):339-345.
Score: 0.641
-
Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics. Semin Cardiothorac Vasc Anesth. 2018 Jun; 22(2):164-173.
Score: 0.568
-
Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma. 2010 May; 68(5):1151-7.
Score: 0.338
-
Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest. J Cardiothorac Vasc Anesth. 2010 Dec; 24(6):959-63.
Score: 0.337
-
Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII. J Cardiothorac Vasc Anesth. 2010 Dec; 24(6):1026-7.
Score: 0.330
-
Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma. Anesth Analg. 2008 Mar; 106(3):719-24, table of contents.
Score: 0.290
-
Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg. 2008 Mar; 106(3):732-8, table of contents.
Score: 0.290
-
Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII. Blood Coagul Fibrinolysis. 2008 Jan; 19(1):106-8.
Score: 0.287
-
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res. 2008; 122(1):117-23.
Score: 0.284
-
Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. Anesth Analg. 2007 Apr; 104(4):763-5.
Score: 0.273
-
Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation. Ann Card Anaesth. 2016 Jul-Sep; 19(3):418-24.
Score: 0.129
-
In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel. Thromb Res. 2013 Jul; 132(1):106-11.
Score: 0.104
-
Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery. Transfusion. 2013 Apr; 53(4):920-1.
Score: 0.103